Matrix Capital Management Company, LP

Holdings History for ADAPTIMMUNE THERAPEUTICS PLC - American Depositary Shares, each representing 6 Ordinary Shares (ADAPY)

Symbol: ADAPY
Investment type: Equity / American Depositary Shares, each representing 6 Ordinary Shares
Latest Disclosed Shares Owned: 0 shares
Security Ownership %: 0%

Shares, Excluding Options vs Price

Value, Excluding Options

Matrix Capital Management Company LP ownership in ADAPTIMMUNE THERAPEUTICS PLC American Depositary Shares, each representing 6 Ordinary Shares (ADAPY)

08 Jan 2025 - Matrix Capital Management Company LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of ADAPTIMMUNE THERAPEUTICS PLC American Depositary Shares, each representing 6 Ordinary Shares (ADAPY). This represents 0% ownership of the company. In their previous filing dated 05 Dec 2024, Matrix Capital Management Company, LP had reported owning 135,000,000 shares, indicating a decrease of +100%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Matrix Capital Management Company LP	0%	-98%	$0	0	-135,000,000	-100%	$0.27	13G/A	31 Dec 2024	08 Jan 2025, 10:30
Matrix Capital Management Company LP	8.8%		$36,450,000	135,000,000			$0.27	13G/A	30 Nov 2024	05 Dec 2024, 17:17

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2024		-1.7%	$0	0	-37,681,515	-100%	$0.03	Q4 2024
30 Sep 2024	1.7%	-0.06%	$35,812,512	37,681,515	-1,292,670	-3.3%	$0.95	Q3 2024
30 Jun 2024	0.29%	0%	$37,995,933	38,974,185	0		$0.97	Q2 2024
31 Mar 2024	0.57%	0%	$61,579,212	38,974,185	0		$1.58	Q1 2024
31 Dec 2023	0.32%	0%	$30,906,529	38,974,185	0		$0.79	Q4 2023
30 Sep 2023	0.36%	0%	$30,399,864	38,974,185	0		$0.78	Q3 2023
30 Jun 2023	0.42%	0%	$36,051,121	38,974,185	0		$0.92	Q2 2023
31 Mar 2023	0.58%	0%	$42,481,862	38,974,185	0		$1.09	Q1 2023
31 Dec 2022	1.1%	0%	$56,902,310	38,974,185	0		$1.46	Q4 2022
30 Sep 2022	0.8%	0%	$41,897,000	38,974,185	0		$1.07	Q3 2022
30 Jun 2022	1.5%	0%	$66,256,000	38,974,185	0		$1.70	Q2 2022
31 Mar 2022	0.96%	0%	$80,287,000	38,974,185	0		$2.06	Q1 2022
31 Dec 2021	1.6%	0%	$146,153,000	38,974,185	0		$3.75	Q4 2021
30 Sep 2021	2.3%	0%	$201,497,000	38,974,185	0		$5.17	Q3 2021
30 Jun 2021	1.8%	0%	$166,030,000	38,974,185	0		$4.26	Q2 2021
31 Mar 2021	2.4%	0%	$206,953,000	38,974,185	0		$5.31	Q1 2021
31 Dec 2020	2.3%	0%	$210,071,000	38,974,185	0		$5.39	Q4 2020
30 Sep 2020	4.1%	0%	$311,014,000	38,974,185	0		$7.98	Q3 2020
30 Jun 2020	6.1%	+0.71%	$390,132,000	38,974,185	+4,545,455	+13%	$10.01	Q2 2020
31 Mar 2020	2.4%	+0.45%	$93,646,000	34,428,730	+6,428,730	+23%	$2.72	Q1 2020
31 Dec 2019	0.72%	0%	$33,600,000	28,000,000	0		$1.20	Q4 2019
30 Sep 2019	1%	0%	$42,280,000	28,000,000	0		$1.51	Q3 2019
30 Jun 2019	2.1%	0%	$112,560,000	28,000,000	0		$4.02	Q2 2019
31 Mar 2019	3.2%	+0.1%	$120,400,000	28,000,000	+851,000	+3.1%	$4.30	Q1 2019
31 Dec 2018	5.2%	+1.3%	$156,107,000	27,149,000	+6,786,989	+33%	$5.75	Q4 2018
30 Sep 2018	6.8%	+2.1%	$276,109,000	20,362,011	+6,278,500	+45%	$13.56	Q3 2018
30 Jun 2018	4.7%	+0.07%	$167,171,000	14,083,511	+201,500	+1.5%	$11.87	Q2 2018
31 Mar 2018	5.4%	+0.65%	$155,895,000	13,882,011	+1,668,500	+14%	$11.23	Q1 2018
31 Dec 2017	2.9%	+0.04%	$81,586,000	12,213,511	+170,000	+1.4%	$6.68	Q4 2017
30 Sep 2017	3.2%	+0.88%	$98,636,000	12,043,511	+3,351,428	+39%	$8.19	Q3 2017
30 Jun 2017	1.3%	+1.3%	$39,027,000	8,692,083	+8,692,083	NEW	$4.49	Q2 2017

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.